For comments, suggestions
Created with Raphaël 2.1.0 17.12.2019 Filing date 16.07.2021 Validation fee payment 30.11.2021 (A1) Patent application published 21.04.2026 AGEPI application filing date

Request for EP validation received


(210)Number of the EPO application19839496
(220)Filing date of the EPO application2019.12.17
(80)EPO patent specification publication (B)EPB nr. 06/2026, 2026.02.04
(110)EPO patent number3897833
(21)Number of the applicatione 2021 1053
(71)Name(s) of applicant(s), code of the countryVERTEX PHARMACEUTICALS INCORPORATED, US;
(72)Name(s) of inventor(s), code of the countryBRODNEY Michael, US;
GAGNON Kevin, US;
HU Kan-Nian, US;
MEDEK Ales, US;
ROSE Peter, US;
SHI Yi, US;
SHRESTHA Muna, US;
WITKOS Faith, US;
CAO Jingrong, US;
COME Jon H., US;
DAKIN Leslie A., US;
DENIS Francois, US;
DORSCH Warren A., US;
FORTIER Anne, US;
HAMEL Martine, US;
KRUEGER Elaine B., US;
LEDFORD Brian, US;
NANTHAKUMAR Suganthini S., US;
NICOLAS Olivier, US;
SAYEGH Camil, US;
SENTER Timothy J., US;
WANG Tiansheng, US;
(73)Name(s) of owner(s), code of the countryVERTEX PHARMACEUTICALS INCORPORATED, US;
(54)Title of the inventionInhibitors of apol1 and methods of using same
(13)Kind-of-document code A1
(51)International Patent Classification A61P 13/12 (2006.01.01); C07D 403/12 (2006.01.01); A61K 31/4025 (2006.01.01)
(52)Cooperative Patent Classification C07D 403/12 (EP); A61P 13/12 (EP)
(19)CountryUS
(41)Date of publication of the application2021.11.30
(30)Priority201862780667 P, 2018.12.17, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/US2019/066746, 2019.12.17
(87)International publicationWO 2020/131807, 2020.06.25
Up
/Inventions/details/3897833